Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland
· Delayed Price · Currency is CHF
14.80
-0.28 (-1.86%)
Apr 29, 2026, 5:30 PM CET
Newron Pharmaceuticals Ratios and Metrics
Market cap in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 314 | 476 | 174 | 88 | 28 | 29 | |
| Market Cap Growth | 124.89% | 173.36% | 97.16% | 219.36% | -4.32% | -24.65% | |
| Enterprise Value | 322 | 485 | 209 | 118 | 44 | 34 | |
| Last Close Price | 15.08 | 23.85 | 8.95 | 4.95 | 1.55 | 1.62 | |
| PE Ratio | - | - | 11.72 | - | - | - | |
| Forward PE | - | - | 10.63 | - | 7.84 | - | |
| PS Ratio | 17.62 | 26.74 | 3.61 | 10.48 | 4.59 | 4.84 | |
| PB Ratio | -30.26 | -45.92 | 127.32 | -3.17 | -1.99 | 8.98 | |
| P/TBV Ratio | - | - | 127.32 | - | - | 8.98 | |
| P/FCF Ratio | 10.43 | 15.83 | - | - | - | - | |
| P/OCF Ratio | 10.42 | 15.81 | - | - | - | - | |
| EV/Sales Ratio | 18.11 | 27.23 | 4.34 | 13.95 | 7.26 | 5.77 | |
| EV/EBITDA Ratio | - | - | 8.52 | - | - | - | |
| EV/EBIT Ratio | - | - | 8.53 | - | - | - | |
| EV/FCF Ratio | 10.72 | 16.12 | - | - | - | - | |
| Debt / Equity Ratio | -3.43 | -3.43 | 34.62 | -1.62 | -3.25 | 13.87 | |
| Debt / EBITDA Ratio | - | - | 1.91 | - | - | - | |
| Debt / FCF Ratio | 1.18 | 1.18 | - | - | - | - | |
| Net Debt / Equity Ratio | -0.83 | -0.83 | 27.88 | -1.20 | -1.63 | 2.73 | |
| Net Debt / EBITDA Ratio | -1.99 | -1.99 | 1.55 | -3.12 | -1.72 | -0.69 | |
| Net Debt / FCF Ratio | 0.29 | 0.29 | -2.31 | -3.53 | -2.06 | -0.74 | |
| Asset Turnover | 0.37 | 0.37 | 1.15 | 0.29 | 0.14 | 0.11 | |
| Quick Ratio | 0.70 | 0.70 | 2.42 | 0.62 | 5.50 | 10.58 | |
| Current Ratio | 0.76 | 0.76 | 2.60 | 0.68 | 5.65 | 10.79 | |
| Return on Equity (ROE) | - | - | - | - | - | -146.43% | |
| Return on Assets (ROA) | -5.65% | -5.65% | 36.44% | -23.05% | -18.96% | -15.19% | |
| Return on Invested Capital (ROIC) | - | -23.34% | 80.74% | -157.51% | -130.08% | -103.26% | |
| Return on Capital Employed (ROCE) | 46.60% | 46.60% | 64.80% | 380.00% | -41.40% | -26.40% | |
| Earnings Yield | -3.93% | -2.59% | 8.54% | -17.09% | -62.50% | -53.44% | |
| FCF Yield | 9.59% | 6.32% | -9.50% | -10.70% | -39.69% | -41.12% | |
| Buyback Yield / Dilution | 2.98% | 2.98% | -15.30% | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.